Compound ID | 775
Class: Protein synthesis inhibitor
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Elongation Factor Tu inhibitor; EF-Tu inhibitor |
| Target Pathogen: | Active against staphylococci and enterococci |
| Description: | N'-p-octyloxybenzylglycyl-vancomycin |
| Institute where first reported: | Chiron Corp. (Novartis, Switzerland) |
| Year first mentioned: | 2005 |
| Development status: | Experimental |
| External links: |